[HTML][HTML] Her2 expression in circulating tumor cells is associated with poor outcomes in patients with metastatic castration-resistant prostate cancer
D Maillet, N Allioli, J Péron, A Plesa… - Cancers, 2021 - mdpi.com
Simple Summary Although the role of HER2 in prostate cancer remains controversial, HER2
can be overexpressed during prostate cancer progression. In this study, we prospectively …
can be overexpressed during prostate cancer progression. In this study, we prospectively …
Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer
D Maillet, N Allioli, J Péron, A Plesa… - …, 2021 - search.proquest.com
HER2-dependent signaling may support the development of metastatic castration-resistant
prostate cancer (mCRPC) by activating androgen receptor signaling through ligand …
prostate cancer (mCRPC) by activating androgen receptor signaling through ligand …
[HTML][HTML] Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer
D Maillet, N Allioli, J Péron, A Plesa… - Cancers, 2021 - ncbi.nlm.nih.gov
HER2-dependent signaling may support the development of metastatic castration-resistant
prostate cancer (mCRPC) by activating androgen receptor signaling through ligand …
prostate cancer (mCRPC) by activating androgen receptor signaling through ligand …
Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer.
D Maillet, N Allioli, J Péron, A Plesa… - Cancers, 2021 - europepmc.org
HER2-dependent signaling may support the development of metastatic castration-resistant
prostate cancer (mCRPC) by activating androgen receptor signaling through ligand …
prostate cancer (mCRPC) by activating androgen receptor signaling through ligand …
Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer.
D Maillet, N Allioli, J Péron, A Plesa… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: Although the role of HER2 in prostate cancer remains
controversial, HER2 can be overexpressed during prostate cancer progression. In this study …
controversial, HER2 can be overexpressed during prostate cancer progression. In this study …
Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer
D Maillet, N Allioli, J Péron, A Plesa… - …, 2021 - pubmed.ncbi.nlm.nih.gov
HER2-dependent signaling may support the development of metastatic castration-resistant
prostate cancer (mCRPC) by activating androgen receptor signaling through ligand …
prostate cancer (mCRPC) by activating androgen receptor signaling through ligand …
[PDF][PDF] Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer. Cancers 2021 …
D Maillet, N Allioli, J Péron, A Plesa… - 2021 - academia.edu
HER2-dependent signaling may support the development of metastatic castration-resistant
prostate cancer (mCRPC) by activating androgen receptor signaling through ligand …
prostate cancer (mCRPC) by activating androgen receptor signaling through ligand …